The Cancer Journal from Scientific American
Overview
The Cancer Journal from Scientific American is a scientific journal, published since 1995 in English. The journal's country of origin is United States and its primary focus area is oncology.
Details
Details
Abbr.
Cancer J Sci Am
Start
1995
End
2000
Frequency
Bimonthly
p-ISSN
1081-4442
Country
United States
Language
English
Specialty
Oncology
Recent Articles
1.
Onishi H, Yamaguchi M, Kuriyama K, Tsukamoto T, Ishigame K, Ichikawa T, et al.
Cancer J Sci Am
. 2000 Mar;
6(1):40-5.
PMID: 10696738
Purpose: The purpose of this study was to explore the effect of concurrent intra-arterial infusion of platinum drugs in patients with stage III or IV uterine cervical cancer treated with...
2.
Yuen A, Fuks J, Ettinger D, Chang A, Ruckdeschel J, Phan S, et al.
Cancer J Sci Am
. 2000 Mar;
6(1):34-9.
PMID: 10696737
Purpose: Six of the most active chemotherapy agents in small cell lung cancer were administered sequentially in a weekly fashion in an attempt to optimize the dose and the number...
3.
Obedian E, Haffty B
Cancer J Sci Am
. 2000 Mar;
6(1):28-33.
PMID: 10696736
Objective: The purpose of this study was to determine the impact of final pathologic margin status on breast relapse-free survival, distant metastasis-free survival, and overall survival in patients undergoing conservative...
4.
Aref A, Youssef E, Washington T, Segel M, Grigorian C, Bongers S, et al.
Cancer J Sci Am
. 2000 Mar;
6(1):25-7.
PMID: 10696735
Purpose: It is recommended that patients with breast cancer who present with mammographically detected microcalcification should undergo postlumpectomy mammogram with magnification views to ensure adequate removal of all clinically demonstrable...
5.
Arun B, Curti B, Longo D, Stevens D, Alvord W, Gause B, et al.
Cancer J Sci Am
. 2000 Mar;
6(1):21-4.
PMID: 10696734
Purpose: Interferon-alfa, 2'-deoxycoformycin, and 2-chlorodeoxy-adenosine (2-CdA) are effective in the management of patients with hairy cell leukemia. These agents produce remissions in most patients, but relapses occur with all three...
6.
Grann V, Jacobson J, Whang W, Hershman D, Heitjan D, Antman K, et al.
Cancer J Sci Am
. 2000 Mar;
6(1):13-20.
PMID: 10696733
Purpose: Recent randomized controlled trials have shown that tamoxifen and raloxifene may prevent invasive breast cancer. This decision analysis study compares the outcomes of chemoprevention with tamoxifen, raloxifene, or oral...
7.
8.
Bartelink H, BEGG A, Martin J, van Dijk M, Moonen L, van t Veer L, et al.
Cancer J Sci Am
. 2000 Mar;
6(1):2-10.
PMID: 10696731
The measurement of the effect of cisplatin on DNA has become feasible with the development of antibodies against DNA adducts. In a phase II dose escalation trial with concomitant radiotherapy...
9.
Huland E, Heinzer H, Huland H, Yung R
Cancer J Sci Am
. 2000 Feb;
6 Suppl 1:S104-12.
PMID: 10685669
Purpose: Locoregional administration of interleukin (IL)-2, which acts physiologically as a local hormone, is an effective therapeutic modality. Diverse preclinical and clinical models have described methods of administration that expose...
10.
Keilholz U, Eggermont A
Cancer J Sci Am
. 2000 Feb;
6 Suppl 1:S99-103.
PMID: 10685668
Purpose: To review the current information available from the European Organization for Research and Treatment of Cancer (EORTC) programs on the use of interleukin (IL)-2 in stage IV melanoma patients....